• Pfizer average price to free cash flow ratio for 2023 was 20.69, a 122% decline from 2022.
• Pfizer average price to free cash flow ratio for 2022 was 9.32, a 4.12% increase from 2021.
• Pfizer average price to free cash flow ratio for 2021 was 9.72, a 26.36% decline from 2020.

Price to free cash flow ratio can be defined as